Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2000
12/07/2000CA2373638A1 Adam polynucleotides and polypeptides
12/07/2000CA2372566A1 Modified cytokine for its stabilisation
12/07/2000CA2372249A1 Chemokine receptor ccr3 antagonists
12/07/2000CA2372246A1 Human tumor necrosis factor receptor tr10
12/07/2000CA2371247A1 Substantially oil-free cyclosporin compositions
12/07/2000CA2336262A1 Sorting nexins
12/06/2000EP1057815A1 Cyclic amide compounds
12/06/2000EP1056869A2 Cell cycle related proteins
12/06/2000EP1056848A1 Human protein kinase c inhibitor
12/06/2000EP1056843A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity
12/06/2000EP1056842A2 Genetic vaccine vector engineering
12/06/2000EP1056761A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE
12/06/2000EP1056760A1 36 human secreted proteins
12/06/2000EP1056714A1 Phenylalanine derivatives as inhibitors of alpha4 integrins
12/06/2000EP1056471A1 TREATING ATOPIC DERMATITIS WITH IgE ANTAGONISTS
12/06/2000EP1056462A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
12/06/2000EP1056455A1 Epimorphian compound and its use
12/06/2000EP1056451A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
12/06/2000EP1056359A1 Product and method to reduce stress induced immune suppression
12/06/2000EP1024701A4 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
12/06/2000EP0597088B1 Novel imidazole derivatives, their preparation and therapeutic applications
12/06/2000CN1275917A Potentiator for antibody against lymphoid tumor
12/06/2000CN1275915A Immunostimulatory and metastais inhibiting fermented vegetal material
12/06/2000CN1275914A Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
12/06/2000CN1275912A Novel amide derivatives
12/06/2000CN1275885A Precise efficary assay methods for active agents including chemotherapeutic agents
12/06/2000CN1275564A Quinoline ketone derivant and antianaphylaction using same as active substance
12/06/2000CN1059102C Immunological powdered Chinese drug
12/05/2000US6156887 Compositions and methods for the treatment and diagnosis of immune disorders
12/05/2000US6156878 Amino acid sequences; for antibodies, immunosuppressants, immunomodulators, immunotoxins, and diagnosis of related disorders
12/05/2000US6156877 Receptor for interleukin-4; has molecular weight of about 200,000 daltons; antitumor agents; immunosuppressants; antibodies
12/05/2000US6156794 Nervous system disorders or alzheimers disease
12/05/2000US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156317 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
11/2000
11/30/2000WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000WO2000071693A2 Method for selecting improved vectors
11/30/2000WO2000071679A2 Human oxidoreductase proteins
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
11/30/2000WO2000071529A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000WO2000071180A1 Bioadhesive hydrogels with functionalized degradable crosslinks
11/30/2000WO2000071160A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY
11/30/2000WO2000071158A1 Tagged epitope protein transposable element
11/30/2000WO2000071154A2 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071129A1 Pyrrolotriazine inhibitors of kinases
11/30/2000WO2000071114A1 Salts of cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate]
11/30/2000WO2000071103A2 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000WO2000071077A2 Adjuvant which is optimized with regard to stability and biocompatibility (sba) and which is provided for increasing the humoral and cellular immune response
11/30/2000WO2000050607A3 Goodpasture antigen binding protein
11/30/2000WO2000047610A3 Method for altering undesirable immune responses to polypeptides
11/30/2000WO2000047559A3 5-ht1f agonists
11/30/2000WO2000044900A3 Nucleic-acid binding proteins
11/30/2000WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
11/30/2000WO2000042201A3 Human peptidases
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000042072A3 Polypeptide variants with altered effector function
11/30/2000WO2000041547A3 Methods of promoting or enhancing interleukin-12 production through administration of thalidomide
11/30/2000WO2000040261A3 Vaccination method for efficient induction of cytotoxic t lymphocyte response
11/30/2000WO2000040241A3 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
11/30/2000WO2000028019A3 Antisense oligomer
11/30/2000WO2000027363A9 Aerosols comprising nanoparticle drugs
11/30/2000DE19924199A1 Tumorassoziiertes Antigen Tumor-associated antigen
11/30/2000DE19923961A1 Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000CA2838395A1 Combination neisserial compositions
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2375543A1 Salts of cis-¬4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate|
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374432A1 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000CA2374413A1 Human oxidoreductase proteins
11/30/2000CA2374296A1 Bioadhesive hydrogels with functionalized degradable crosslinks
11/30/2000CA2374070A1 Tagged epitope protein transposable element
11/30/2000CA2373992A1 Medicinal compositions containing anti-fas antibody
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373239A1 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response
11/30/2000CA2372580A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase
11/29/2000EP1055668A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/29/2000EP1055429A1 Novel preventives/remedies for immunopathy
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054968A1 Apoptosis inducing molecule ii and methods of use
11/29/2000EP1054961A2 Human short-chain tnf-receptor family protein
11/29/2000EP1054958A1 Human serine protease and serpin polypeptides
11/29/2000EP1054953A1 NOVEL pgsA
11/29/2000EP1054950A2 Hiv chemokines
11/29/2000EP1054905A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054901A2 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use
11/29/2000EP1054880A1 TREATMENT OF MULTIPLE SCLEROSIS USING COP-1 AND Th2-ENHANCING CYTOKINES
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000EP1054867A1 Antivirals
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000EP1054693A1 Inhibitors of complement activation
11/29/2000EP1054692A2 Antibodies against human cd40
1 ... 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 ... 1172